Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Thiabendazole poisoning of undetermined intent |
Causative agent (attribute) |
False |
Tiabendazole |
Inferred relationship |
Some |
1 |
Thiabendazole adverse reaction (disorder) |
Causative agent (attribute) |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Allergy to tiabendazole |
Causative agent (attribute) |
False |
Tiabendazole |
Inferred relationship |
Some |
|
Thiabendazole overdose |
Causative agent (attribute) |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Accidental thiabendazole overdose |
Causative agent (attribute) |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Intentional thiabendazole overdose |
Causative agent (attribute) |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Thiabendazole overdose of undetermined intent |
Causative agent (attribute) |
False |
Tiabendazole |
Inferred relationship |
Some |
1 |
Product containing tiabendazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Poisoning by thiabendazole |
Causative agent (attribute) |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Tiabendazole 500 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tiabendazole |
Inferred relationship |
Some |
|
Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tiabendazole |
Inferred relationship |
Some |
|
Accidental thiabendazole poisoning (disorder) |
Causative agent (attribute) |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Intentional thiabendazole poisoning |
Causative agent (attribute) |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Allergy to tiabendazole |
Causative agent (attribute) |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Tiabendazole 500 mg chewable tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Tiabendazole 500 mg chewable tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Product containing tiabendazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Product containing only tiabendazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |
Product containing only tiabendazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tiabendazole |
Inferred relationship |
Some |
1 |